Our Cardiovascular Innovations division develops partnerships with industry to facilitate clinical research trials, translational research and technology adoption. We launched this division in 2013 and now provide services to a range of global pharmaceutical companies, cardiovascular research departments at leading Universities and the medical devices industry. Our service focuses on medicines, devices and techniques that seamlessly integrate into front-line service delivery, leading to efficiency gains and enhanced outcomes for patients.
Please contact us via this email: enquiries@regentsparkhealthcare.com
